These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6273470)

  • 1. Use of cell differentiation effectors to select a human B lymphoblastoid cell line enriched in C3b receptors.
    Barel M; Charriaut C; Frade R
    J Immunol Methods; 1981; 46(2):187-95. PubMed ID: 6273470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of particle-bound [125I]C3b, the third component of complement, with specific receptors on human B-lymphoblastoid cells (Raji).
    Frade R; Strominger J
    Immunol Lett; 1981 Aug; 3(3):173-8. PubMed ID: 6974688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior of soluble human 125I-labeled C3b, the third component of complement, after binding to human cells.
    Charriaut C; Barel M; Frade R
    Eur J Immunol; 1982 Apr; 12(4):289-94. PubMed ID: 6980121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a C3b receptor-like molecule from membranes of a human B lymphoblastoid cell line (Raji).
    Barel M; Charriaut C; Frade R
    FEBS Lett; 1981 Dec; 136(1):111-4. PubMed ID: 6976275
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotype characteristics of human B cells studied by Epstein-Barr virus infection. III. In vitro modulation of C3 receptor expression on human lymphoid cells.
    Kudo T; Tachibana T
    Immunol Lett; 1984; 8(6):349-53. PubMed ID: 6098556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple solid phase radioimmunoassay specific for human C3b to detect C3b receptors on human lymphoblastoid cell surfaces.
    Barel M; Charriaut C; Frade R
    Int Arch Allergy Appl Immunol; 1983; 71(1):1-5. PubMed ID: 6219958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    Theofilopoulos AN; Dixon FJ; Bokisch VA
    J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement receptor expression by neoplastic and normal human cells.
    Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
    J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of complement C3b and C3d surface receptors on neoplastic IgM positive B lymphocytes.
    Jønsson V; Christensen BE; Videbaek A
    Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):269-74. PubMed ID: 6976063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-associated complement factor H on lymphoblastoid cell lines Raji expresses a co-factor activity for the factor I-mediated cleavage of C3b.
    Demares MJ
    Immunology; 1989 Aug; 67(4):553-6. PubMed ID: 2527806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes.
    Theofilopoulos AN; Perrin LH
    J Exp Med; 1976 Feb; 143(2):271-89. PubMed ID: 1082488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dimethyl sulfoxide and dimethylformamide on the growth and morphology of tumor cells.
    Borenfreund E; Steinglass M; Korngold G; Bendich A
    Ann N Y Acad Sci; 1975 Jan; 243():164-7. PubMed ID: 165760
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    Fearon DT
    J Exp Med; 1980 Jul; 152(1):20-30. PubMed ID: 6967510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymic assay of C3b receptor on intact cells and solubilized cells.
    Sim E; Sim RB
    Biochem J; 1983 Feb; 210(2):567-76. PubMed ID: 6222733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.
    Atkinson JP; Jones EA
    J Clin Invest; 1984 Nov; 74(5):1649-57. PubMed ID: 6334100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for the fourth component of complement on human B lymphocytes and cultured human lymphoblastoid cells.
    Bokisch VA; Sobel AT
    J Exp Med; 1974 Nov; 140(5):1336-47. PubMed ID: 4547573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of soluble 125I-human C3b, the third component of complement, to specific receptors in human cultured B lymphoblastoids cells: characterization of a low affinity interaction.
    Frade R; Strominger J
    J Immunol; 1980 Sep; 125(3):1332-9. PubMed ID: 6967899
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphoblastoid cell supernatants increase expression of C3b receptors on human polymorphonuclear leucocytes: direct binding studies with 125I-C3b.
    Berger M; Cross AS
    Immunology; 1984 Mar; 51(3):431-40. PubMed ID: 6230308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.